← back

Binaries

Every upcoming binary — PDUFAs and readouts. Call it.
PCVX VAX-31 Ph3
Ph3 Oct'26
--
no votes yet
AGIO mitapivat PDUFA
PDUFA November 1, 2026
--
no votes yet
CYTK aficamten PDUFA
PDUFA November 14, 2026
--
no votes yet
SMMT ivonescimab (HARMONi BLA) Ph3
Ph3 November 14, 2026
--
no votes yet
CAPR deramiocel PDUFA
PDUFA November 22, 2026
--
no votes yet
SNY venglustat Ph3
Ph3 November 25, 2026
--
no votes yet
BBIO BBP-418 PDUFA
PDUFA November 27, 2026
--
no votes yet
COGT bezuclastinib PDUFA
PDUFA November 30, 2026
--
no votes yet
DWTX Halneuron Ph2
Ph2 Nov'26
--
no votes yet
PEPG PGN-EDODM1 Ph2
Ph2 Nov'26
--
no votes yet
RXRX REC-4881 Ph2
Ph2 Nov'26
--
no votes yet
SLGL SGT-610 (patidegib gel 2%) Ph3
Ph3 Nov'26
--
no votes yet
MLYS Lorundrostat PDUFA
PDUFA December 22, 2026
--
no votes yet
PRAX relutrigine (PRAX-562) PDUFA
PDUFA December 27, 2026
--
no votes yet
ACRS bosakitug (ATI-045) Ph2
Ph2 Q4'26
--
no votes yet
AMGN dazodalibep Ph3
Ph3 Q4'26
--
no votes yet
ANNX vonaprument Ph3
Ph3 Q4'26
--
no votes yet
ARQT ZORYVE foam 0.3% Ph2
Ph2 Q4'26
--
no votes yet
AXSM solriamfetol Ph3
Ph3 Q4'26
--
no votes yet
BDTX silevertinib Ph3
Ph3 Q4'26
--
no votes yet
BNTX trastuzumab pamirtecan Ph3
Ph3 Q4'26
--
no votes yet
CLLS lasme-cel Ph3
Ph3 Q4'26
--
no votes yet
EPRX EP-104GI Ph2
Ph2 Q4'26
--
no votes yet
GMAB EPKINLY Ph3
Ph3 Q4'26
--
no votes yet
GMAB Rina-S Ph3
Ph3 Q4'26
--
no votes yet
GPCR aleniglipron Ph2
Ph2 Q4'26
--
no votes yet
IGC IGC-AD1 Ph2
Ph2 Q4'26
--
no votes yet
INCY Ruxolitinib cream (Opzelura) Ph3
Ph3 Q4'26
--
no votes yet
IVA lanifibranor Ph3
Ph3 Q4'26
--
no votes yet
JSPR KP-104 (vensobafusp alfa) Ph2
Ph2 Q4'26
--
no votes yet
KPTI selinexor Ph3
Ph3 Q4'26
--
no votes yet
KRYS KB803 Ph3
Ph3 Q4'26
--
no votes yet
KYNB FG-3246 Ph2
Ph2 Q4'26
--
no votes yet
KYTX miv-cel Ph2
Ph2 Q4'26
--
no votes yet
OGEN ONP-002 Ph2
Ph2 Q4'26
--
no votes yet
ORKA ORKA-001 Ph2
Ph2 Q4'26
--
no votes yet
PBLS zolucatetide Ph3
Ph3 Q4'26
--
no votes yet
PBYI alisertib Ph2
Ph2 Q4'26
--
no votes yet
PFE mevrometostat Ph3
Ph3 Q4'26
--
no votes yet
PGEN PRGN-2009 Ph2
Ph2 Q4'26
--
no votes yet
PHAT vonoprazan (VOQUEZNA) Ph2
Ph2 Q4'26
--
no votes yet
PRAX relutrigine (PRAX-562) Ph3
Ph3 Q4'26
--
no votes yet
RARE UX701 Ph3
Ph3 Q4'26
--
no votes yet
RGNX RGX-314 (surabgene lomparvovec / ABBV-RGX-314) Ph3
Ph3 Q4'26
--
no votes yet
SLS SLS009 (tambiciclib) Ph2
Ph2 Q4'26
--
no votes yet
SNDX axatilimab (frontline cGVHD) Ph2
Ph2 Q4'26
--
no votes yet
SYRE SPY072 (PsA) Ph2
Ph2 Q4'26
--
no votes yet
SYRE SPY072 (axSpA) Ph2
Ph2 Q4'26
--
no votes yet
TARA IV Choline Chloride Ph3
Ph3 Q4'26
--
no votes yet
TARA TARA-002 (STARBORN-1) Ph2
Ph2 Q4'26
--
no votes yet
TNYA TN-201 Ph3
Ph3 Q4'26
--
no votes yet
TNYA TN-401 Ph3
Ph3 Q4'26
--
no votes yet
VIR elebsiran plus tobevibart Ph3
Ph3 Q4'26
--
no votes yet
VNDA tradipitant Ph3
Ph3 Q4'26
--
no votes yet
ZURA tibulizumab Ph2
Ph2 Q4'26
--
no votes yet
CRVS soquelitinib Ph2
Ph2 Q4'26
--
no votes yet
ACRV ACR-368 Ph2
Ph2 H2'26
--
no votes yet
ADCT ZYNLONTA (loncastuximab tesirine-lpyl) Ph2
Ph2 2026
--
no votes yet
ALKS alixorexton (ALKS 2680) Ph2
Ph2 2026
--
no votes yet
ALNY ALN-6400 Ph2
Ph2 H2'26
--
no votes yet
ANAB Quimilza (imsidolimab) PDUFA
PDUFA 2026
--
no votes yet
BBIO infigratinib Ph2
Ph2 2026
--
no votes yet
BHVN opakalim Ph2
Ph2 2026
--
no votes yet
BHVN taldefgrobep alfa Ph2
Ph2 2026
--
no votes yet
BIOA BGE-102 Ph2
Ph2 2026
--
no votes yet
BNTX BNT113 Ph3
Ph3 2026
--
no votes yet
CHRS casdozokitug Ph2
Ph2 2026
--
no votes yet
CRIS Emavusertib Ph2
Ph2 Dec'26
--
no votes yet
CRSP CTX611 Ph2
Ph2 2026
--
no votes yet
CRVO neflamapimod Ph2
Ph2 2026
--
no votes yet
DNTH claseprubart Ph2
Ph2 Dec'26
--
no votes yet
EXEL zanzalintinib Ph3
Ph3 2026
--
no votes yet
FTH PIK-201 Ph2
Ph2 2026
--
no votes yet
GNLX Olvi-Vec Ph3
Ph3 2026
--
no votes yet
GSK neladalkib PDUFA
PDUFA H2'26
--
no votes yet
IMCR tebentafusp Ph3
Ph3 2026
--
no votes yet
IMUX vidofludimus calcium Ph3
Ph3 2026
--
no votes yet
IPHA monalizumab Ph3
Ph3 H2'26
--
no votes yet
KOD KSI-101 (PEAK Pivotal Analysis 1) Ph3
Ph3 Dec'26
--
no votes yet
KPRX KIO-104 Ph2
Ph2 2026
--
no votes yet
KPTI selinexor Ph2
Ph2 H2'26
--
no votes yet
KYMR KT-621 (BROADEN2) Ph2
Ph2 2026
--
no votes yet
LYEL ronde-cel Ph3
Ph3 H2'26
--
no votes yet
MAZE MZE829 Ph2
Ph2 2026
--
no votes yet
MBRX Annamycin (naxtarubicin) Ph3
Ph3 Dec'26
--
no votes yet
MNOV MN-166 (ibudilast) Ph2
Ph2 2026
--
no votes yet
NAMS Obicetrapib Ph3
Ph3 2026
--
no votes yet
NBP Givastomig Ph3
Ph3 2026
--
no votes yet
NBP VIS-101 Ph2
Ph2 H2'26
--
no votes yet
NCNA NUC-7738 Ph2
Ph2 2026
--
no votes yet
NVS ianalumab Ph3
Ph3 2026
--
no votes yet
PCRX PCRX-201 Ph2
Ph2 2026
--
no votes yet
PCRX ZILRETTA Ph3
Ph3 2026
--
no votes yet
RLMD NDV-01 Ph3
Ph3 2026
--
no votes yet
RLMD sepranolone Ph2
Ph2 2026
--
no votes yet
RNTX LTI-03 Ph2
Ph2 2026
--
no votes yet
ROIV brepocitinib Ph3
Ph3 2026
--
no votes yet
RZLT ersodetug Ph2
Ph2 2026
--
no votes yet
SMMT ivonescimab (HARMONi-3, squamous PFS) Ph3
Ph3 H2'26
--
no votes yet
SNY Sarclisa (isatuximab) Ph3
Ph3 2026
--
no votes yet
TGTX BRIUMVI (ublituximab), subcutaneous quarterly regimen Ph3
Ph3 2026
--
no votes yet
VNDA Quimilza (imsidolimab) PDUFA
PDUFA 2026
--
no votes yet
VRTX povetacicept PDUFA
PDUFA 2026
--
no votes yet